Richard Marshak, Chief Commercial Officer of TriSalus Life Sciences, Inc. ($TLSI), made one open market sale of company shares in the last 365 days, totaling $34,172 on May 19, 2025. He ranks 10,711th out of 11,678 insiders by sale value, well below the average of $8.6 million across about six transactions per insider. Marshak made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 12, 2026 | TriSalus Life Sciences, Inc. | $TLSI | Marshak Richard | Chief Commercial Officer | S | Common Stock | 1589 | $4.09 | 110,816.0000 | 49,964,311 | 1.41% | 0.00% |
| March 11, 2026 | TriSalus Life Sciences, Inc. | $TLSI | Marshak Richard | Chief Commercial Officer | S | Common Stock | 1449 | $4.13 | 112,405.0000 | 49,964,311 | 1.27% | 0.00% |
| March 16, 2026 | TriSalus Life Sciences, Inc. | $TLSI | Marshak Richard | Chief Commercial Officer | S | Common Stock | 419 | $4.12 | 110,397.0000 | 49,964,311 | 0.38% | 0.00% |
| Nov. 24, 2025 | TriSalus Life Sciences, Inc. | $TLSI | Marshak Richard | Chief Commercial Officer | A | Employee Stock Option (right to buy) | 120000 | $0.00 | 408,937.0000 | 49,964,311 | 41.53% | 0.24% |
| Nov. 24, 2025 | TriSalus Life Sciences, Inc. | $TLSI | Marshak Richard | Chief Commercial Officer | A | Common Stock | 60000 | $0.00 | 113,854.0000 | 49,964,311 | 111.41% | 0.12% |
| May 19, 2025 | TriSalus Life Sciences, Inc. | $TLSI | Marshak Richard | Chief Commercial Officer | A | Common Stock | 21428 | $5.18 | 75,698.0000 | 32,272,462 | 39.48% | 0.07% |
| May 19, 2025 | TriSalus Life Sciences, Inc. | $TLSI | Marshak Richard | Chief Commercial Officer | S | Common Stock | 6597 | $5.18 | 69,101.0000 | 32,272,462 | 8.71% | 0.02% |
| Feb. 18, 2025 | TriSalus Life Sciences, Inc. | $TLSI | Marshak Richard | Chief Commercial Officer | A | Common Stock | 7644 | $0.00 | 54,270.0000 | 0 | 16.39% | 0.00% |
| Jan. 27, 2025 | TriSalus Life Sciences, Inc. | $TLSI | Marshak Richard | Chief Commercial Officer | A | Employee Stock Option (right to buy) | 75000 | $0.00 | 75,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 27, 2025 | TriSalus Life Sciences, Inc. | $TLSI | Marshak Richard | Chief Commercial Officer | A | Common Stock | 12500 | $0.00 | 46,626.0000 | 0 | 36.63% | 0.00% |
| Nov. 14, 2024 | TriSalus Life Sciences, Inc. | $TLSI | Marshak Richard | SR.VP, CORP. DEV. & STRATEGY | A | Common Stock | 6875 | $0.00 | 34,126.0000 | 0 | 25.23% | 0.00% |
| Nov. 14, 2024 | TriSalus Life Sciences, Inc. | $TLSI | Marshak Richard | SR.VP, CORP. DEV. & STRATEGY | A | Employee Stock Option (right to buy) | 41250 | $0.00 | 41,250.0000 | 0 | 9999.99% | 0.00% |
| Feb. 12, 2024 | TriSalus Life Sciences, Inc. | $TLSI | Marshak Richard | SR.VP, CORP. DEV. & STRATEGY | A | Common Stock | 14752 | $0.00 | 27,251.0000 | 0 | 118.03% | 0.00% |
| Feb. 12, 2024 | TriSalus Life Sciences, Inc. | $TLSI | Marshak Richard | SR.VP, CORP. DEV. & STRATEGY | A | Employee Stock Option (right to buy) | 63750 | $0.00 | 63,750.0000 | 0 | 9999.99% | 0.00% |
| Jan. 24, 2024 | TriSalus Life Sciences, Inc. | $TLSI | Marshak Richard | SR.VP, CORP. DEV. & STRATEGY | A | Employee Stock Option (right to buy) | 40000 | $0.00 | 40,000.0000 | 0 | 9999.99% | 0.00% |